Stanozolol (Winstrol): A Tracking Guide and Lipid Warning

Stanozolol, sold as Winstrol, is a DHT-derived anabolic steroid available in both oral and injectable forms (the injectable is a water-based suspension, not an oil). It is associated with a hard, dry, vascular look and strength without water retention, which is why it shows up in cutting and athletic contexts. It is also notorious for severely damaging cholesterol and for joint and tendon discomfort.

This is an educational tracking guide. Stanozolol is controlled in many places. The lipid and joint issues here are the headline.

What it does

• Strength and a "dry," hard appearance without estrogenic water retention
• Does not aromatise
• 17-alpha-alkylated (liver-stressing) in both oral and injectable forms
• Strongly suppresses HDL cholesterol - among the harshest steroids for lipids
• Frequently reported to cause dry, achy joints and tendon issues
• Suppresses the HPTA

What to track daily

• Dose, form (oral or injectable suspension), timing
• Strength and performance
• Joint and tendon comfort - log pain and stiffness, this is a real risk
• Libido and mood
• Liver flags (dark urine, RUQ pain, yellowing)
• Hair shedding and acne in predisposed users

What to track weekly

• Blood pressure
• Bodyweight and waist (little water, so changes are leaner)
• Strength
• Joint comfort trend

Bloodwork worth doing

• Baseline: full lipid panel, liver panel, testosterone, full blood count, kidney panel
• During (week 2-3) and after: repeat
• Lipids are the critical metric - HDL can crater; liver enzymes also need watching due to alkylation

Realistic expectations

• The "dry, hard" look is real at low body fat; it does not add water-driven size
• Joint discomfort is a common complaint and can affect training
• Lipid damage can be substantial even on short cycles

Common mistakes

• Ignoring the dramatic HDL suppression because the mirror looks good
• Training through tendon pain (injury risk rises)
• Long cycles compounding liver and lipid stress
• No baseline lipid panel

A tracking template

• Pre: baseline lipids, liver, testosterone
• On: daily logs including joint pain, weekly BP and weight, labs around week 2-3
• Post: recheck lipids and liver; both need to recover

Safety notes

Severe HDL suppression and adverse lipids, liver strain (both oral and injectable are alkylated), joint and tendon discomfort with raised injury risk, HPTA suppression, and hair-loss risk in predisposed users. Controlled; close lipid and liver monitoring under a physician are essential.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.